Carbidopa-Levodopa 25 Mg-100 Mg Oral Tablet + Naproxen 500 Mg + Opioids for opioid-related disorders

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 Jan 2021: Trial started, NCT05463367
  2. 19 Jul 2022: Trial registered, NCT05463367

The trials

NCT05463367: Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure

State
Under way
Phase
Phase 2
People
60 taking part
Started
1 Jan 2021
Primary completion
1 Jun 2025
Arms
Chronic Back Pain with Opioid Use, Chronic Back Pain with Opioid Misuse Disorder
Results
None posted
  1. 1 Jan 2021: Trial started
  2. 19 Jul 2022: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.